Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Approval    crawled time : 13:00    save search

Chesapeake Utilities Corporation Gains Approval to Establish Energy Efficiency Programs in Delaware
Published: 2024-04-22 (Crawled : 13:00) - prnewswire.com
CPK | News | $106.89 1.16% 0.0% 150K twitter stocktwits trandingview |
Utilities
| | O: -0.01% H: 0.94% C: 0.88%

energy approval corporation
Foresight Granted Patent Approval in Japan for All-Weather and Lighting Conditions Vision System
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
FRSX | $1.08 1.89% 1.85% 12K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 1.74% C: -0.87%

patent japan granted approval system vision for
Elys BMG Group Announces Approval for The Ugly Mug Sportsbook in Washington, DC.
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ELYS | $0.1302 14.4% 2.5K twitter stocktwits trandingview |
Consumer Services
| Email alert Add to watchlist

approval group for
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.2 -0.07% 0.0% 19K twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.28% C: 0.0%

approval for meeting
GAF Energy Receives Miami-Dade County Approval for Solar Roof
Published: 2024-04-03 (Crawled : 13:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K twitter stocktwits trandingview |
Retail Trade
| | O: -0.04% H: 0.71% C: -1.05%

energy approval solar roof
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
CELU | News 4 | $3.385 5.45% 5.17% 36K twitter stocktwits trandingview |
| | O: 1.52% H: 0.0% C: -5.98%

biovance services approval system
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8407 -13.92% -16.18% 1.7M twitter stocktwits trandingview |
| | O: -0.73% H: 3.31% C: 0.74%

elyxyb drug patent company health approval review treatment canada migraine submission
Elys BMG Group Announces Approval For Grand Central’s H Street Sportsbook in Washington, DC.
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
ELYS | $0.1302 14.4% 2.5K twitter stocktwits trandingview |
Consumer Services
| | O: 1.95% H: 7.83% C: 1.97%

approval group
Crescent Point Receives Approval for Normal Course Issuer Bid
Published: 2024-03-07 (Crawled : 13:00) - prnewswire.com
CPG | $8.85 -0.11% -0.57% 4.5M twitter stocktwits trandingview |
Energy Minerals
| | O: 0.53% H: 1.32% C: -0.26%

approval crescent
Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
EYEN | $0.5897 8.68% 7.99% 770K twitter stocktwits trandingview |
Health Technology
| | O: -2.19% H: 0.0% C: -21.08%

fda ocular approval treatment pharmaceuticals
NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-02-29 (Crawled : 13:00) - prnewswire.com
NRBO | $3.09 2.32% 2.27% 39K twitter stocktwits trandingview |
Health Technology
| | O: 9.32% H: 6.66% C: 3.45%

da-1726 obesity first approval treatment pharmaceuticals trial
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
Published: 2024-02-22 (Crawled : 13:00) - globenewswire.com
ICU 4 | $0.5085 3.8% 3.66% 1.8M twitter stocktwits trandingview |
| | O: 17.59% H: 0.7% C: -34.9%

fda device kidney approval grants
J&J Wins Bi-Weekly Dosing Approval from FDA for Tecvayli in Multiple Myeloma
Published: 2024-02-21 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: 0.0%

fda tecvayli approval
Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1587 1.21% 1.2% 950K twitter stocktwits trandingview |
Health Technology
| | O: 5.61% H: 3.54% C: 3.54%

fda fibromyalgia approval positive pharmaceuticals trial
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1587 1.21% 1.2% 950K twitter stocktwits trandingview |
Health Technology
| | O: 1.81% H: 0.88% C: -6.29%

fda management drug fibromyalgia approval pharmaceuticals application submission
Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
Published: 2024-02-12 (Crawled : 13:00) - globenewswire.com
CDTX | News | $11.94 16.49% 14.15% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 4.1% C: -3.42%

approval million payment rezzayo therapeutics milestone
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
IKT | $1.64 3.8% 3.66% 62K twitter stocktwits trandingview |
Health Technology
| | O: -9.06% H: 5.35% C: 0.37%

fda approval blood meeting gastrointestinal therapeutics
Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
CMND | $1.19 -1.65% -1.68% 26K twitter stocktwits trandingview |
n/a
| | O: 4.92% H: 9.38% C: -8.59%

patent approval treatment china
CVRx receives FDA approval for expanded labeling of Barostim
Published: 2023-12-26 (Crawled : 13:00) - globenewswire.com
CVRX | $14.4 0.77% 0.76% 120K twitter stocktwits trandingview |
| | O: 0.04% H: 24.72% C: 24.16%

fda approval cvrx
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
Published: 2023-12-26 (Crawled : 13:00) - globenewswire.com
SXTP | $0.2506 -2.45% 130K twitter stocktwits trandingview |
n/a
| | O: 33.08% H: 27.5% C: -3.75%

fda pharma approval meeting study
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.